NCT07422532: An ongoing trial by Imperial College London
This trial is ongoing. It must report results 1 year, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07422532 |
|---|---|
| Title | An Open-label, Multi-centre, Randomised Controlled Trial to Assess the Efficacy, Safety and Utility of Automated Insulin Delivery in People With Type 2 Diabetes and Sub-optimal Glycaemia Undergoing Haemodialysis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 1, 2026 |
| Completion date | April 1, 2027 |
| Required reporting date | March 31, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 11, 2026 |
| Days late | None |